Montreal: April 15th, 2025– AtkinsRéalis, a world-class engineering services and nuclear company with offices around the world, welcomes Novartis Canada as a new ambassador in support of the Canadians for CANDU campaign.

Novartis Canada is leading the way in bringing an innovative targeted cancer treatment called radioligand therapy to Canadian patients. This approach uses radioactive particles attached to molecules that seek out and destroy cancer cells while minimizing harm to healthy tissue. For certain advanced cancers, such as prostate and neuroendocrine cancers, this therapy can offer significant benefits. The radioactive materials essential for these treatments are often sourced from the nuclear industry, underscoring the vital link between pharmaceutical innovation in cancer care and the supply of medical isotopes.

The Canadians for CANDU campaign was launched on February 28, 2024, and is proudly supported by organizations including organized labour, supply chain, nuclear medicine, education, and Indigenous Canadian organizations. Spearheaded by Co-Chairs the Right Honourable Jean Chrétien and former Ontario Premier Mike Harris, the campaign promotes the deployment of CANDU® nuclear technology at home and abroad in support of Canadian and global efforts to reach net-zero emissions.

“I would like to thank Novartis Canada for their leadership in Canada’s world class nuclear sector, and their support for CANDU technology,” said Joe St. Julian, President, Nuclear, AtkinsRéalis. “This growing movement can position Canada as a global clean energy champion, while promoting a domestic nuclear industry that Canadians can be proud of.”

“At Novartis Canada, our leadership in radioligand therapy is driven by a commitment to improving the lives of patients,” said Céline Landie, Vice-President Radioligand Therapy, Novartis Canada. “The reliable supply of medical isotopes, many of which are produced through CANDU technology, is vital for the continued advancement and accessibility of our targeted cancer treatments. We are proud to stand alongside other Canadian leaders in recognizing the role CANDU plays in our healthcare ecosystem and look forward to a strong collaboration.”

Sign up at canadiansforcandu.com to support the movement and follow on LinkedIn.